Myeloid suppressor cells require membrane TNFR2 expression for suppressive activity

Abstract

TNF and TNF receptor type 2 (TNFR2) have been shown to be important for generation of myeloid-derived suppressor cells (MDSC). In order to analyze whether and how TNFR2 passes the effect of TNF on, myeloid cells from TNFR2-deficient mice were compared to respective cells from wild-type mice. Primary TNFR2-deficient myeloid cells showed reduced production of NO and IL-6 which was attributable to CD11b+ CD11c− Ly6C+ Ly6G− immature monocytic MDSC. TNFR2-deficient MDSC isolated from bone marrow were less suppressive for T cell proliferation compared to WT-derived MDSC. These differences on myeloid cells between the two mouse lines were still observed after co-culture of bone marrow cells from the two mouse lines together during myeloid cell differentiation, which demonstrated that the impaired functional capacity of TNFR2-deficient cells was independent of soluble factors but required membrane expression of TNFR2. Similarly, adoptive transfer of TNFR2-deficient bone marrow cells into wild-type hosts did not rescue the TNFR2-specific phenotype of bone marrow-derived myeloid cells. Therefore, membrane TNFR2 expression determines generation and function of monocytic MDSC.

Inflammation markers in cutaneous melanoma - edgy biomarkers for prognosis

“…Stimulated MDSC release an orchestrated cascade of mediators (ARG1, iNOS, NO, ROS, IL-10, TGF-beta) that finally leads to a suppressed immune response 91 . Later studies have shown that membrane-bound TNFR2 is involved, independently of the soluble form 92 . In addition, TNFR2 are also expressed on a subset of Tregs potentiating the anti-inflammatory character and tumor tolerance 93 .…”

TNFR2 induced priming of NLRP3-inflammasome via RIPK1 leads to pyroptosis in XIAP deficient cells

“…TNFR2 has been shown to promote survival, differentiation and promote a immune suppressive function (Polz et al, 2014;Zhao et al, 2012). However, our data suggest the opposite in the absence of XIAP.…”

TNFR2 and Regulatory T Cells: Potential Immune Checkpoint Target in Cancer Immunotherapy

“…Tumor microenvironment preferably recruits TNFR2+ Treg cells which possess a highly immunosuppressive capacity, thus facilitating tumor immune escape. That TNFR2 knockout mice show improved immune responses to tumors might be caused by the lack of TNFR2 expressing Treg or have failed to develop systemic autoimmunity [59] or the decreased numbers and the impaired function of MDSCs [60]. In humans, the high level of TNFR2+ Treg is found in the peripheral blood of lung cancer patients [10] and in the tumor-associated ascites in ovarian cancer patients [61].…”